SCHEMBL10293222

SCHEMBL10293222

CCC(C)(C)Cc1cc(OC)cc(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
CYP19A1 P11511 1/20 0.44
PTGS2 P35354 1/20 0.41
TSHR P16473 2/20 0.40
MAPK1 P28482 1/20 0.40
CALM1 P0DP23 4/20 0.38
AKR1B1 P15121 1/20 0.38
CYP1A1 P04798 2/20 0.37
CYP1B1 Q16678 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2E1 P05181 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP4B1 P13584 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP3A5 P20815 1/20 0.36
CYP2A7 P20853 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21727714 0.82 ALDH1A1 (0.44) ALDH1A1CYP19A1PTGS2TSHRMAPK1
SCHEMBL13064708 0.81 TAAR1 (0.51) ALDH1A1CYP3A4
SCHEMBL856046 0.80 ALDH1A1 (0.52) ALDH1A1CYP19A1PTGS2TSHRMAPK1
SCHEMBL12841723 0.79 IDO1 (0.48) ALDH1A1TSHRMAPK1CALM1CYP3A4
SCHEMBL10207847 0.77 ALDH1A1 (0.48) ALDH1A1CYP19A1PTGS2TSHRCALM1
SCHEMBL19969483 0.76 ALDH1A1 (0.37) ALDH1A1CYP19A1PTGS2CYP1A1CYP1B1
SCHEMBL24939942 0.72 MMP1 (0.43) PTGS2CALM1CYP1A2CYP3A4CYP2A6
SCHEMBL88823 0.72 ALDH1A1 (0.61) ALDH1A1CYP19A1PTGS2TSHRMAPK1
SCHEMBL18977863 0.71 ALDH1A1 (0.41) ALDH1A1CYP19A1PTGS2CALM1AKR1B1
SCHEMBL13144840 0.71 CA2 (0.57) ALDH1A1CYP19A1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022098-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022098-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR MAP3K20, MAP3K13, MAP3K8 ALDH1A1 4348/4885CYP19A1 3363/4885PTGS2 2625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.